Three-dose vaccine prevents HIV patients getting hepatitis B
Clinical trial results suggest adult HIV patients can be protected against hepatitis B with a three-dose vaccine series.
List view / Grid view
Clinical trial results suggest adult HIV patients can be protected against hepatitis B with a three-dose vaccine series.
Active pharmaceutical ingredients (APIs) are primary components in the manufacture of drugs, yet this global market experiences numerous challenges. Regulatory pressure, pricing arbitrages, a shift to digital manufacturing and patents for blockbuster drugs are chief among them, but the COVID-19 pandemic added a further hurdle as governments globally decided to…
By investigating norovirus outbreaks, US researchers at the University of Rochester in New York hope that the development of a norovirus vaccine will occur...
Researchers apply machine learning to create a quick and easy method for measuring changes linked to cardiovascular disease...
We caught up with Naghmana Bajwa, MD, Global Medical Affairs Haematology Lead at Shire to find out the latest in haemophilia disease research...